Phosphorylation- and polo-box-dependent binding of Plk1 to Bub1 is required for the kinetochore localization of Plk1

被引:121
|
作者
Qi, Wei [1 ]
Tang, Zhanyun [1 ]
Yu, Hongtao [1 ]
机构
[1] Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA
关键词
D O I
10.1091/mbc.E06-03-0240
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Polo-like kinase 1 (PIk1) is required for the generation of the tension-sensing 3F3/2 kinetochore epitope and facilitates kinetochore localization of Mad2 and other spindle checkpoint proteins. Here, we investigate the mechanism by which PIk1 itself is recruited to kinetochores. We show that PIk1 binds to budding uninhibited by benzimidazole 1 (Bub1) in mitotic human cells. The PIk1-Bub1 interaction requires the polo-box domain (PBD) of PIk1 and is enhanced by cyclin-dependent kinase 1 (Cdk1)-mediated phosphorylation of Bub1 at T609. The PBD-dependent binding of PIk1 to Bub1 facilitates phosphorylation of Bub1 by PIk1 in vitro. Depletion of Bub1 in HeLa cells by RNA interference (RNAi) diminishes the kinetochore localization of PIk1. Ectopic expression of the wild-type Bub1, but not the Bub1-T609A mutant, in Bub1-RNAi cells restores the kinetochore localization of PIk1. Our results suggest that phosphorylation of Bub1 at T609 by Cdk1 creates a docking site for the PBD of PIk1 and facilitates the kinetochore recruitment of PIk1.
引用
收藏
页码:3705 / 3716
页数:12
相关论文
共 50 条
  • [41] A novel strategy for PLK1 kinase inhibition by allosterically targeting the Polo Box Domain.
    Chapagai, Danda
    Baxter, Merissa
    Craig, Sandra
    Ramamoorthy, Guru
    Stafford, Jessy
    Vitali, Sikirzhytski
    Nurmemmedov, Elmar
    McInnes, Campbell
    Wyatt, Michael D.
    CANCER RESEARCH, 2022, 82 (12)
  • [42] p53-dependent repression of polo-like kinase-1 (PLK1)
    McKenzie, Lynsey
    King, Sharon
    Marcar, Lynnette
    Nicol, Sam
    Dias, Sylvia S.
    Schumm, Katie
    Robertson, Pamela
    Bourdon, Jean-Christophe
    Perkins, Neil
    Fuller-Pace, Frances
    Meek, David W.
    CELL CYCLE, 2010, 9 (20) : 4200 - 4212
  • [43] CCT chaperonin complex is required for the biogenesis of functional Plk1
    Liu, XQ
    Lin, CY
    Lei, M
    Yan, S
    Zhou, TH
    Erikson, RL
    MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (12) : 4993 - 5010
  • [44] Cullin' PLK1 from kinetochores
    Colleen A. McGourty
    Michael Rape
    Nature Cell Biology, 2013, 15 : 347 - 348
  • [45] Plk1 in Asthma: Ready for Primetime?
    Tam, John Kit Chung
    Tran, Thai
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2022, 66 (02) : 124 - 125
  • [46] PLK1 AS A THERAPEUTIC TARGET IN ATRT
    Alimova, Irina
    Pierce, Angela M.
    Venkataraman, Sujatha
    Harris, Peter
    Birks, Diane K.
    Amani, Vladimir M.
    Prince, Eric
    Balakrishnan, Ilango
    Foreman, Nicholas K.
    Vibhakar, Rajeev
    NEURO-ONCOLOGY, 2016, 18 : 2 - 2
  • [47] Targeting Plk1 for cancer therapy
    Schmidt, Mathias
    Hofmann, Hans-Peter
    Sanders, Karl
    Gekeler, Volker
    Beckers, Thomas
    EJC SUPPLEMENTS, 2006, 4 (06): : 16 - 16
  • [48] Comparative Analysis of a FRET-based PLK1 Kinase Assay to Identify PLK1 inhibitors for Chemotherapy
    Shin, Sol-Bi
    Woo, Sang-Uk
    Lee, Young-Joo
    Yim, Hyungshin
    ANTICANCER RESEARCH, 2017, 37 (03) : 1177 - 1183
  • [49] PLK1 Regulates MicroRNA Biogenesis through Drosha Phosphorylation
    Fletcher, Claire Emily
    Taylor, Molly Ann
    Bevan, Charlotte Lynne
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (18)
  • [50] PLK1 (polo like kinase 1) inhibits MTOR complex 1 and promotes autophagy
    Ruf, Stefanie
    Heberle, Alexander Martin
    Langelaar-Makkinje, Miriam
    Gelino, Sara
    Wilkinson, Deepti
    Gerbeth, Carolin
    Schwarz, Jennifer Jasmin
    Holzwarth, Birgit
    Warscheid, Bettina
    Meisinger, Chris
    van Vugt, Marcel A. T. M.
    Baumeister, Ralf
    Hansen, Malene
    Thedieck, Kathrin
    AUTOPHAGY, 2017, 13 (03) : 486 - 505